Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Due Date Calculator
Collaborate
About
EQOH
Careers
Contact Us
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
EMJ GOLD
CME
search
Join
FREE
This site is intended for healthcare professionals
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Due Date Calculator
Collaborate
About
EQOH
Careers
Contact Us
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
EMJ GOLD
CME
Join
FREE
Edition
European
US
Neurology
Filter
Journals
About
Congress reviews
Abstracts
Articles
Podcasts
Videos & Webinars
News
Infographics
Submit A Paper
Brivaracetam in the Real World: Tackling Unmet Needs in FOS
4
Mins
December 2025
Many people living with focal onset seizures (FOS) fail to achieve seizure freedom, even after taking two or more anti-seizure..
Read more
8
Mins
13 Aug 2024
Update on Daridorexant for Insomnia
During this symposium, held at the 10th Congress of the European Academy of Neurology (EAN), speakers highlighted that chronic insomnia…
2
Mins
13 Aug 2024
Nipocalimab and gMG: Top Line Results from the Phase III Vivacity-MG3 Study
Nipocalimab, a high-affinity, fully human, aglycosylated, effectorless, monoclonal antibody, has been developed as an add-on treatment…
5
Mins
13 Aug 2024
Diagnosing Synucleinopathies
Parkinson’s disease (PD) is the second-most common neurodegenerative disease after Alzheimer’s disease (AD), with an estimated…
9
Mins
13 Aug 2024
Patterns of Laryngeal Changes on Clinical Application of Mechanical Insufflation-Exsufflation
Individuals with neuromuscular diseases (NMD), where deterioration in bulbar function coexists with respiratory muscle weakness, are at…
10
Mins
13 Aug 2024
A Rare Case of Cervical Intramedullary Spinal Cord Abscess
The occurrence of intramedullary spinal cord abscesses (ISCA) is rare, a phenomenon attributable to a confluence of physiological and…
5
Mins
13 Aug 2024
Bromocriptine in the Management of Central Hyperthermia
Fever is a common medical issue encountered in neurorehabilitation units. The most common cause of fever is infection; the common…
7
Mins
1 Aug 2024
Interview: Kailash Bhatia
I completed my neurology training in Mumbai, India. At the end of my general medical degree, I was influenced by a top-rate neurologist…
6
Mins
19 Jul 2024
Roundtable Interview: Olivier Rascol and Wassilios Meissner
When I started as a neurologist and a clinical pharmacologist, there were a lot of interesting developments in movement disorders…
Loading posts...
« Previous
1
…
4
5
6
7
8
…
24
Next »
We’ve noticed you’re accessing
from
North/South America.
View
View